Incidental discovery of a dural arteriovenous fistula in a patient with activated protein C resistance

American Journal of Neuroradiology

Volumn 24, Issue 7, 2003, Pages 1369-1371

  Wenderoth, Jason D ^a   Phatouros, Constantine C ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; HEPARIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTERIOVENOUS FISTULA; ARTICLE; BRAIN ANGIOGRAPHY; CASE REPORT; CLINICAL FEATURE; HEPARINIZATION; HUMAN; INTRACRANIAL ANEURYSM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PARESTHESIA; SUPERIOR SAGITTAL SINUS; SYMPTOM; VERTIGO;

ACTIVATED PROTEIN C RESISTANCE; CAROTID ARTERY, INTERNAL; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; CEREBRAL ANGIOGRAPHY; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENTAL FINDINGS; INTRACRANIAL ANEURYSM; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; VERTEBROBASILAR INSUFFICIENCY;

EID: 0041972725     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Cognard C, Houdart E, Casasco AE, et al. Endovascular therapy for intracranial dural arteriovenous fistulas. In: Connors JJ, Wojak JC, eds. Interventional Neuroradiology: Strategies and Practical Techniques. Philadelphia: Saunders; 1999:198-214
2. Kraus JA, Stuper BK, Berlit P. Association of resistance to activated protein C and dural arteriovenous fistulas. J Neurol 1998;245:731-733
3. Kraus JA, Stuper BK, Nahser HC, et al. Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas. J Neurol 2000;247:521-523
4. Kraus JA, Stuper BK, Muller J, et al. Molecular analysis of thrombophilic risk factors in patients with dural arteriovenous fistulas. J Neurol 2002;249:680-682
5. Dahlbck B. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis. J Intern Med (Suppl) 1997;740:1-8
6. Hoerl HD, Tabares A, Kottke-Marchant K. The diagnosis and clinical manifestations of activated protein C resistance: a case report and review of the literature. Vasc Med 1996;1:275-280
7. Handin RI. Disorders of coagulation and thrombosis. In: Fauci AS, Braunwald, E, Isselbacher KJ, eds. Harrison's Principles of Internal Medicine. Vol 1. 14th ed. New York: McGraw-Hill; 1998:742-743
8. Provenzale JM, Barboriak DP, Ortel TL. Dural sinus thrombosis with acivated protein C resistance: MR imaging findings and proband identification. AJR Am J Roentgenol 1998;170:499-502
9. Dulli DA, Luzzio CC, Williams EC, Schutta HS. Cerebral venous thrombosis and activated protein C resistance. Stroke 1996;27:1731-1733
10. Van Dijk JM, TerBrugge KG, Willinsky RA, et al. Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients. Stroke. 2002;33:1578-1583
11. Kim MS, Han DH, Kwon OK, et al. Clinical characteristics of dural arteriovenous fistula. J Clin Neurosci 2002;9:147-155